Parallel49 Equity has sold MedTorque to ARCH Medical Solutions, a portfolio company of The Jordan Company
MedTorque is a world-class precision manufacturer of orthopedic instruments and implants with facilities in Kenosha, Wisconsin, and Elmhurst, Illinois. The company serves market-leading medical platforms, providing engineering and manufacturing services for a wide range of orthopedic applications, including robotic surgery, spinal fusion and spinal arthroplasty, upper and lower extremities and large joint reconstruction. MedTorque also offers a portfolio of silicone handles, ratchet drivers and torque-limiting drivers that can be custom engineered to customers’ requirements.
In partnership with Parallel49, MedTorque established itself as a leading provider of precision-manufactured orthopedic instruments and custom drivers, through completion of key strategic initiatives, including facility, infrastructure, salesforce and capability expansions. Through entrenched relationships with market-leading customers and deep expertise in robotic surgery instruments, MedTorque attracted interest from global strategics and private equity alike. As part of ARCH Medical Solutions, MedTorque is well positioned to continue executing on its strategic growth plan.
Cynthya Goulet, Managing Director in Lincoln’s Healthcare Group, commented, “There continues to be strong interest in the medical device contract development and manufacturing organization market globally, despite some recent disruptions due to COVID-19, including lower elective surgery volumes, supply chain delays and rising material input costs. We are pleased to see a great company such as MedTorque join forces with a high-quality partner in ARCH Medical Solutions.”
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.